Search results
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
Motley Fool via Yahoo Finance· 3 months agoThe stock market has given investors plenty to talk about over the last few years, and those who have stayed in it through the ups and downs have dealt...
Regeneron Science Talent Search 2024: See Westchester's 26 high school semifinalists
Lohud | The Journal News via Yahoo News· 4 months agoThe country's oldest math and science competition for high school seniors announced its...
Roche reports survival data for new dual-acting lymphoma drug
BioPharma Dive via Yahoo Finance· 2 weeks agoDive Brief: Roche’s new dual-acting blood cancer drug Columvi combined with chemotherapy helped...
Biotech Stock Roundup: BMY's Opdivo Updates, Pipeline Updates From REGN, BIIB
Zacks via Yahoo Finance· 2 years agoThe biotech sector has been in the spotlight in the past week, with regular pipeline and regulatory...
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Motley Fool· 2 years agoRegeneron Pharmaceuticals (NASDAQ: REGN), Vertex Pharmaceuticals (NASDAQ: VRTX), and Biogen (NASDAQ:...
CRISPR Stocks: Will Concerns Over Risk Inhibit Gene-Editing Cures?
Investor's Business Daily· 2 years agoA cure for genetic diseases has been little more than a whisper — until now. Thanks to the work of...
Gene Therapy Could Be On the Cusp of a Major Breakthrough, but Investors May Have to Remain Patient
Motley Fool· 6 months agoOn Sept. 14, 1990, Ken Griffey Jr. and Ken Griffey Sr. made history by hitting back-to-back home...
2 Biotech Stocks You Can Buy and Hold for the Next Decade
Motley Fool· 10 months agoBiotech companies use living organisms to develop their therapies, and much like some living things,...
The Zacks Analyst Blog Highlights bluebird, Editas Medicine, Beam Therapeutics and Intellia...
Zacks via Yahoo Finance· 5 months agoFor Immediate Release Chicago, IL – December 14, 2023 – Zacks.com announces the list of stocks...
Exelixis' Growth Trajectory Depends on Leading Innovations in Cancer Treatments
GuruFocus.com via Yahoo Finance· 2 months agoExelixis Inc. (NASDAQ:EXEL) is a pharmaceutical company headquartered in Alameda, California that...